Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [14910]

WCLC 2024: Phase II study of taletrectinib shows clinically meaningful overall response and favorable safety in patients with ROS1+ non-small cell lung cancer

WCLC 2024: Phase II study of taletrectinib shows clinically meaningful overall response and favorable safety in...

WCLC 2024: Results from CARMEN-LC03 phase 3 study of tusamitamab ravtansine vs. docetaxel in previously treated advanced non-squamous NSCLC

WCLC 2024: Results from CARMEN-LC03 phase 3 study of tusamitamab ravtansine vs. docetaxel in previously treated...

PM2.5 exposure may affect lung cancer in women who have never smoked

PM2.5 exposure may affect lung cancer in women who have never smoked

Researchers compare tumour characteristics, survival outcome of different bile duct cancers

Researchers compare tumour characteristics, survival outcome of different bile duct cancers

Risk of secondary cancers after CAR T therapy may be similar to risk after other cancer treatments

Risk of secondary cancers after CAR T therapy may be similar to risk after other cancer treatments

University develops novel bone cancer therapy which has 99% success rate

University develops novel bone cancer therapy which has 99% success rate

Can chatbots help with genetic testing for cancer risk?

Can chatbots help with genetic testing for cancer risk?

WCLC 2024: Aumolertinib maintenance after chemoradiotherapy in stage III non-small cell lung cancer improves PFS compared to placebo

WCLC 2024: Aumolertinib maintenance after chemoradiotherapy in stage III non-small cell lung cancer improves PFS...

MicroDicer and MicroGrater make quick work of tumour dissection

MicroDicer and MicroGrater make quick work of tumour dissection

Evolving the framework of cancer theory

Evolving the framework of cancer theory

More from ecancer